Skip to main content
OpenTrials

Clinical trial condition

Crohn Disease

Explore clinical trials studying Crohn Disease. Study availability and eligibility vary by location and protocol.

493 public trials 136 recruiting studies
Refine in advanced search Browse all conditions

Crohn Disease trial results

Recruiting

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

NCT07196722

Conditions
Crohn Disease, Digestive System Diseases, Gastroenteritis, +3 more
Locations
  • AZ Gastro Care Chandler, Arizona, United States
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Clinnova Research Anaheim, California, United States
View all 372 locations
View Trial Details
Recruiting

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

NCT07499232

Conditions
Crohn Disease, Digestive System Diseases, Gastroenteritis, +3 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • East View Medical Research Mobile, Alabama, United States
  • Clinnova Research Anaheim, California, United States
  • United Gastroenterologists Los Alamitos, California, United States
View all 161 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)

NCT07310095

Conditions
Crohn Disease, Digestive System Diseases, Gastroenteritis, +3 more
Locations
  • The First Affiliated Hospital Sun Yat sen University Guangzhou, China
  • The Sixth Affiliated Hospital Sun Yat sen University Guangzhou, China
  • Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, China
View Trial Details
Recruiting

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT03816345

Conditions
Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, +59 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
View all 52 locations
View Trial Details
Recruiting

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

NCT07483073

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Mayo Clinic in Arizona - Scottsdale Scottsdale, Arizona, United States
  • Biopharma Informatic, LLC Los Angeles, California, United States
  • Om Research LLC Oxnard, California, United States
  • South Denver Gastroenterology Englewood, Colorado, United States
View all 70 locations
View Trial Details
Recruiting

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

NCT07483099

Conditions
Crohn Disease, Digestive System Diseases, Gastroenteritis, +3 more
Locations
  • Mayo Clinic in Arizona - Scottsdale Scottsdale, Arizona, United States
  • Biopharma Informatic, LLC Los Angeles, California, United States
  • Om Research LLC Oxnard, California, United States
  • South Denver Gastroenterology Englewood, Colorado, United States
View all 70 locations
View Trial Details

Related conditions